loading page

How community pharmacists are responding during COVID-19 in Malaysia: A cross-sectional survey
  • Kok Pim Kua,
  • Shaun Lee
Kok Pim Kua
Puchong Health Clinic (Petaling District Health Office)
Author Profile
Shaun Lee
Monash University Malaysia
Author Profile


Background Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has resulted in profound health challenges across the globe. Objective This study aims to examine community pharmacists’ views on their work environment, policies, and preparedness for safe retail patronage to prevent the transmission of COVID-19. Setting An online survey of pharmacists practicing in community pharmacy setting in Malaysia. Method A questionnaire-based, cross-sectional study was conducted in Malaysia to evaluate coping strategies of community pharmacists and pharmaceutical services provided during COVID-19 pandemic. Between May 1 and July 31, 2020, the questionnaire was distributed to pharmacists working in community setting nationwide utilizing a snowball sampling method. Main outcome measure Community pharmacists’ perceptions on safety, resilience, organizational support, and pharmaceutical services offered during COVID-19 pandemic. Results A total of 217 pharmacists participated in the study. Most community pharmacists had reported a positive outlook and were able to balance working with self-care during this period. Most had reported to have access to personal protective equipment such as gloves and hand sanitizers. A large proportion of community pharmacies also installed physical barriers in doorways or in front of the counter, put markings on the ground to section areas to ensure physical distancing, and controlled the number of customers who could access the pharmacy during this period. Innovations reported to be implemented included teleconsultations and providing curb-side or drive-through delivery and pickups. Conclusion The findings suggest the front-line and essential roles of community pharmacists in delivering pandemic responses, creating the opportunity to determine areas where community pharmacy services can be incorporated to strengthen the public health system and improve patient health outcomes.

Peer review status:UNDER REVIEW

21 Oct 2020Submitted to International Journal of Clinical Practice
22 Oct 2020Submission Checks Completed
22 Oct 2020Assigned to Editor
26 Oct 2020Reviewer(s) Assigned
27 Dec 2020Review(s) Completed, Editorial Evaluation Pending
12 Mar 20211st Revision Received
13 Mar 2021Submission Checks Completed
13 Mar 2021Assigned to Editor
03 Jun 2021Reviewer(s) Assigned